The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study
Launched by CHINA-JAPAN FRIENDSHIP HOSPITAL · Feb 19, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how axial spondyloarthritis (axSpA), a type of inflammatory arthritis that mostly affects the spine, progresses over time. Researchers want to understand changes in patients' symptoms, physical function, and imaging results to get a clearer picture of the disease in real-world situations. The trial is currently recruiting participants who are 18 years or older and have been diagnosed with axSpA based on specific criteria. However, individuals with serious health issues related to the heart, kidneys, blood, or hormonal systems, as well as those with certain mental health conditions or who are pregnant or breastfeeding, will not be eligible to participate.
If you join this study, you can expect to provide information about your health and undergo assessments that track your symptoms and abilities over time. This research aims to improve understanding of axSpA and could ultimately help in developing better treatments. Your participation could play an important role in advancing knowledge about this condition and its impact on people's lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 years or older and diagnosed with the Assessment of Spondyloarthritis International Society axial spondyloarthritis criteria.
- Exclusion Criteria:
- • Patients with serious disease in cardiovascular, kidney and blood and endocrine system; history of schizophrenia or epilepsy; pregnant or in lactation period.
About China Japan Friendship Hospital
China-Japan Friendship Hospital is a leading clinical research institution dedicated to advancing healthcare through innovative medical research and trials. Established as a collaborative effort between China and Japan, the hospital integrates cutting-edge technology with traditional medical practices, fostering a multidisciplinary approach to patient care and clinical studies. The institution is committed to enhancing therapeutic outcomes and improving patient safety while adhering to rigorous ethical standards. With a diverse team of experienced healthcare professionals and researchers, China-Japan Friendship Hospital plays a pivotal role in addressing global health challenges and contributing to medical knowledge through its extensive clinical trial programs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported